Literature DB >> 32402337

Evidence of vertical transmission of novel astrovirus virus in goose.

Feng Wei1, Jing Yang1, Dalin He1, Youxiang Diao2, Yi Tang3.   

Abstract

In 2019, a novel goose astrovirus (GoAstV) epidemiological investigation on geese was conducted in Shandong province, China. During the investigation, a high prevalence of novel GoAstV was observed in symptom-free breeding geese flocks. Moreover, the novel GoAstV-specific RNA was detected in either breeder birds or their progenies. To verify the hypothesis that the novel GoAstV could be transmitted vertically, a total of 42 WuLong breeder geese, aged 335 days, were equally divided into three groups for experimental infection. The SDPY isolate of novel GoAstV (A/goose/Shandong/SDPY/2018, SDPY), preserved in our laboratory, was injected intramuscularly to subjects of group A while orally inoculated to those of group B. After the inoculation, novel GoAstV RNA was detected in vitelline membrane, embryos, and allantoic fluid of goose embryos in novel GoAstV infected groups. Moreover, the ORF2 gene of novel GoAstV from vitelline membrane, embryo, allantoic fluid as well as gosling shared almost 100 % nucleotide homology to a novel GoAstV virus isolated from the goose ovary which produced the egg, suggesting that the novel GoAstV can be vertically transmitted in the goose. Taken together, the findings provide evidence of possible vertical transmission of novel GoAstV from breeding goose to goslings.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Breeding goose; Gosling; Novel goose astrovirus; Vertical transmission

Mesh:

Substances:

Year:  2020        PMID: 32402337     DOI: 10.1016/j.vetmic.2020.108657

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Core antigenic advantage domain-based ELISA to detect antibody against novel goose astrovirus in breeding geese.

Authors:  Zeng Wang; Huayuan Chen; Shenyan Gao; Mingzhen Song; Zicong Shi; Zhifeng Peng; Qianyue Jin; Li Zhao; Hongxing Qiao; Chuanzhou Bian; Xia Yang; Xiaozhan Zhang; Jun Zhao
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-07       Impact factor: 4.813

2.  Insight into the Epidemiology and Evolutionary History of Novel Goose Astrovirus-Associated Gout in Goslings in Southern China.

Authors:  Xinliang Fu; Zhanpeng Hou; Wenjun Liu; Nan Cao; Yu Liang; Bingxin Li; Danli Jiang; Wanyan Li; Danning Xu; Yunbo Tian; Yunmao Huang
Journal:  Viruses       Date:  2022-06-15       Impact factor: 5.818

3.  Extensive genetic heterogeneity and molecular characteristics of emerging astroviruses causing fatal gout in goslings.

Authors:  Hao Cui; Xinhao Mu; Xin Xu; Jun Ji; Ke Ma; Chaoliang Leng; Lunguang Yao; Yunchao Kan; Yingzuo Bi; Qingmei Xie
Journal:  Poult Sci       Date:  2022-04-05       Impact factor: 4.014

4.  Genome Analysis of Goose-Origin Astroviruses Causing Fatal Gout in Shanghai, China Reveals One of Them Belonging to a Novel Type Is a Recombinant Strain.

Authors:  Quan Shen; Zi Zhuang; Juan Lu; Lingling Qian; Guangquan Li; Aaron Gia Kanton; Shixing Yang; Xiaochun Wang; Huiying Wang; Jun Yin; Wen Zhang
Journal:  Front Vet Sci       Date:  2022-06-17

Review 5.  Goose Astrovirus in China: A Comprehensive Review.

Authors:  Qinghe Zhu; Dongbo Sun
Journal:  Viruses       Date:  2022-08-12       Impact factor: 5.818

Review 6.  A Review of Emerging Goose Astrovirus Causing Gout.

Authors:  Chenggang Liu; Minhua Sun; Ming Liao
Journal:  Biomed Res Int       Date:  2022-08-28       Impact factor: 3.246

Review 7.  Intra- and Cross-Species Transmission of Astroviruses.

Authors:  Shanley N Roach; Ryan A Langlois
Journal:  Viruses       Date:  2021-06-11       Impact factor: 5.048

8.  Development of a potential diagnostic monoclonal antibody against capsid spike protein VP27 of the novel goose astrovirus.

Authors:  Miao Zhang; Xuan Lv; Bei Wang; Shengzu Yu; Qi Lu; Ying Kan; Xiqiang Wang; Beiping Jia; Zhuangli Bi; Qing Wang; Yingqi Zhu; Guijun Wang
Journal:  Poult Sci       Date:  2021-12-23       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.